Series C - Affectis Pharmaceuticals
Investment Firm
Overview
Affectis Pharmaceuticals is a pharmaceuticals company developing novel drugs.
Announced Date
Oct 24, 2006
Funding Type
Series C
Highlights
Location
Europe
Social
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
 Aescap Venture |
Round Details and Background
Affectis Pharmaceuticals raised $15073786 on 2006-10-24 in Series C
Affectis Pharmaceuticals is a pharmaceuticals company developing novel drugs.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Nov 01, 2003 |  Series A - Affectis Pharmaceuticals | 1 | - | undefined |
| Oct 24, 2006 | Series C - Affectis Pharmaceuticals | 1 | - | 15.1M |
| Oct 19, 2005 | Series B - Affectis Pharmaceuticals | 1 | - | 4.8M |
| Mar 22, 2010 | Series D - Affectis Pharmaceuticals | 5 | - | 4.5M |
Recent Activity
There is no recent news or activity for this profile.